29 June 2022 - NICE has published a second appraisal consultation document on the use of zanubrutinib for the treatment ...
28 June 2022 - Theramex to commercialise Yselty; ObsEva to receive royalties on commercial sales, as well as development, commercial, and ...
29 June 2022 - TAs 799 and 800 are for the same technology. ...
27 June 2022 - NHS England and Improvement has announced the launch of the Innovative Medicines Fund. The ABPI’s Director ...
24 June 2022 - MHRA extends UCB’s therapy for the treatment of partial-onset seizures. ...
23 June 2022 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
23 June 2022 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
22 June 2022 - NICE has announced its decision to reject Fampyra – also known as fampridine – for use ...
21 June 2022 - The Department of Health and Social Care has asked NICE to produce guidance on using slow-release ...
14 June 2022 - Application is based on data from pivotal Phase 3 AENEAS trial in the first-line treatment of EGFR ...
21 June 2022 - The Department of Health and Social Care has asked NICE to produce guidance on using tebentafusp ...
16 June 2022 - NICE has provisionally approved a new treatment for early breast cancer that it says will benefit ...
15 June 2022 - The NHS is set to roll out two ‘superbug’ busting drugs through a world first, pioneering ...
16 June 2022 - These are the International Medical Device Regulatory Forum, the International Council for Harmonisation of Technical Requirements for ...
16 June 2022 - Innovation passport awarded to molgramostim for the treatment of auto-immune pulmonary alveolar proteinosis, a rare lung disease. ...